BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7081823)

  • 1. Elevation of serum chemotactic factor inactivator activity during acute inflammatory reactions in patients with hypersensitivity pneumonitis.
    Kreutzer DL; McCormick JR; Thrall RS; Hupp JR; Moore VL; Fink JN
    Am Rev Respir Dis; 1982 May; 125(5):612-4. PubMed ID: 7081823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of serum chemotactic factor inactivator activity in rabbits induced by inflammation and chemotactic factor.
    Hupp JR; Despins AW; McCormick JR; Armstrong G; Kreutzer DL
    Am J Pathol; 1982 Dec; 109(3):277-82. PubMed ID: 7180941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in activities of anaphylatoxin inactivator and chemotactic factor inactivator during hemodialysis.
    McCormick JR; Kreutzer DL; Keating HJ; Hupp J; Despins A; Moore M
    Am J Pathol; 1982 Dec; 109(3):283-7. PubMed ID: 7180942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass.
    Kreutzer DL; McCormick JR; Despins A; Moore M; Rousou JH; Dobbs W; Engleman RN
    J Exp Pathol; 1984; 1(3):183-7. PubMed ID: 6336305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of chemotactic factor inactivation in neutrophil chemotaxis.
    Tannous R; Cavender-Zylich N; Ginsberg BH
    J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
    Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI
    J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of chemotactic factor inactivator by cigarette smoke. A potential mechanism of modulating neutrophil recruitment to the lung.
    Robbins RA; Gossman GL; Nelson KJ; Koyama S; Thompson AB; Rennard SI
    Am Rev Respir Dis; 1990 Oct; 142(4):763-8. PubMed ID: 2221580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional loss of chemotactic factor inactivator in the adult respiratory distress syndrome.
    Robbins R; Maunder R; Gossman G; Kendall T; Hudson L; Rennard S
    Am Rev Respir Dis; 1990 Jun; 141(6):1463-8. PubMed ID: 2350087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of chemotactic factor inactivator in alcoholic liver disease.
    Robbins RA; Zetterman RK; Kendall TJ; Gossman GL; Monsour HP; Rennard SI
    Hepatology; 1987; 7(5):872-7. PubMed ID: 3653852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships between serum chemotactic factor inactivator, alpha 1-antitrypsin deficiency, and chronic obstructive lung disease.
    Lam S; Chan-Yeung M; Abboud R; Kreutzer D
    Am Rev Respir Dis; 1980 Mar; 121(3):507-12. PubMed ID: 6968167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.
    Robbins RA; Hamel FG
    J Immunol; 1990 Mar; 144(6):2371-6. PubMed ID: 2313096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
    Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
    J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An animal model of hypersensitivity pneumonitis in rabbits. Development of chronic pulmonary inflammation and cell-mediated hypersensitivity after repeated aerosol challenge.
    Peterson LB; Braley JF; Calvanico NJ; Moore VL
    Am Rev Respir Dis; 1979 Jun; 119(6):991-9. PubMed ID: 88200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the protease activity in the chemotactic factor inactivator.
    Ward PA; Ozols J
    J Clin Invest; 1976 Jul; 58(1):123-9. PubMed ID: 6489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of immune complex-induced inflammation by the chemotactic factor inactivator.
    Johnson KJ; Anderson TP; Ward PA
    J Clin Invest; 1977 May; 59(5):951-8. PubMed ID: 140184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased chemotactic activity in activated newborn plasma.
    Tannous R; Spitzer RE; Clarke WR; Goplerud CP; Cavendar-Zylich N
    J Lab Clin Med; 1982 Mar; 99(3):331-41. PubMed ID: 7057060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hypersensitivity pneumonitis: serial changes in lung lymphocyte subopulations after exposure to antigen.
    Bernardo J; Hunninghake GW; Gadek JE; Ferrans VJ; Crystal RG
    Am Rev Respir Dis; 1979 Nov; 120(5):985-94. PubMed ID: 315742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical quantitation of the chemotactic factor inactivator activity in human serum.
    Fantone J; Senior RM; Kreutzer DL; Jones M; Ward PA
    J Lab Clin Med; 1979 Jan; 93(1):17-24. PubMed ID: 759526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity pneumonitis in nonhuman primates. I. Studies on the relationship of immunoregulation and disease activity.
    Keller RH; Calvanico NJ; Stevens JO
    J Immunol; 1982 Jan; 128(1):116-22. PubMed ID: 6172473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.